glucagon like peptide 1 glp 1 agonists Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Glucagon-like peptide-1 receptor: mechanisms and
Description
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Whether you're on a GLP-1 medication and want complementary support, or you're taking the natural route entirely, this patch was made for you
Can you use GLP-1 medications if you have Crohn's disease
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been studied for their cardiovascular benefits in type 2 diabetes

Designed to complement your GLP-1 journey
It is prescribed to patients with diabetes
